| __timestamp | Cytokinetics, Incorporated | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 3004000 |
| Thursday, January 1, 2015 | 46398000 | 26972000 |
| Friday, January 1, 2016 | 59897000 | 58187000 |
| Sunday, January 1, 2017 | 90296000 | 79479000 |
| Monday, January 1, 2018 | 89135000 | 94123000 |
| Tuesday, January 1, 2019 | 86125000 | 114249000 |
| Wednesday, January 1, 2020 | 96951000 | 131328000 |
| Friday, January 1, 2021 | 159938000 | 150991000 |
| Saturday, January 1, 2022 | 240813000 | 206997000 |
| Sunday, January 1, 2023 | 330123000 | 255000000 |
| Monday, January 1, 2024 | 312068000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, understanding cost structures is pivotal. Over the past decade, from 2014 to 2023, Incyte Corporation and Cytokinetics, Incorporated have showcased intriguing trends in their cost of revenue. Cytokinetics started with a modest cost of revenue, but by 2023, it surged by over 640%, reflecting its aggressive expansion and investment in research. Incyte, on the other hand, demonstrated a steady increase, with a notable 8,400% rise from 2014 to 2023, indicating its strategic scaling and operational efficiency.
These trends underscore the dynamic nature of the biotech industry, where strategic investments in R&D can lead to substantial financial shifts.
Novo Nordisk A/S vs Cytokinetics, Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Cytokinetics, Incorporated
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Incyte Corporation
Cost Insights: Breaking Down Zoetis Inc. and Cytokinetics, Incorporated's Expenses
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Incyte Corporation
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
Incyte Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
Analyzing Cost of Revenue: Cytokinetics, Incorporated and CRISPR Therapeutics AG
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Ligand Pharmaceuticals Incorporated
Cost of Revenue Comparison: Cytokinetics, Incorporated vs MiMedx Group, Inc.